Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization

Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115.

OBJECTIVES. The short- and long-term effectiveness of transmyocardial laser revascularization was evaluated in the setting of an acute myocardial infarction. BACKGROUND. Theoretically, transmyocardial laser revascularization allows direct perfusion of the ischemic area as ventricular blood flows through the channels to the myocardium. METHODS. Infarcts were created by coronary occlusion in 30 sheep. Eighteen of these sheep were studied to assess short-term efficacy. The infarct was reperfused after 1 h by either removing the occlusion or by laser drilling using a high power carbon dioxide laser. The occlusions were left in place for the control group. To monitor regional recovery, percent systolic shortening was measured. To evaluate long-term effectiveness, 12 additional sheep underwent creation of an infarct. Six were treated with the laser, and six were untreated. The animals were restudied 30 days later. RESULTS. In the short-term experiment, the control and reperfusion groups exhibited no recovery of regional contractility. The laser group demonstrated improvement throughout the recovery period. There was a significant difference in the area of necrosis within the same area at risk (reperfusion group 44 +/- 6% and control group 39 +/- 5% vs. laser group 6 +/- 2%). After 30 days, none of the control animals showed evidence of contraction in the infarct, whereas the laser-treated animals did. Histologic analysis of the laser-treated infarcts revealed patent channels surrounded by viable myocardium. The control-group infarcts were necrotic and scarred. CONCLUSIONS. On the basis of both short- and long-term improved contractility, as well as diminished necrosis in the area at risk, these results indicate that transmyocardial laser revascularization may be an alternative method of treating ischemic heart disease.

This article has been cited by other articles:

				K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text]

				D. Spiegelstein, C. Kim, Y. Zhang, G. Li, R. D. Weisel, R.-K. Li, and T. M. Yau Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3311 - H3316. [Abstract] [Full Text] [PDF]

				K. A. Horvath, C. Y. J. Lu, E. Robert, G. F. Pierce, R. Greene, B. A. Sosnowski, and J. Doukas Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1071 - 1077. [Abstract] [Full Text] [PDF]

				R. J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P. C. Deedwania, J. S. Douglas, T. B. Ferguson Jr, S. D. Fihn, T. D. Fraker Jr, J. M. Gardin, et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) Circulation, January 7, 2003; 107(1): 149 - 158. [Full Text] [PDF]

				Committee Members, R. J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P. C. Deedwania, J. S. Douglas, T. B. Ferguson Jr, S. D. Fihn, T. D. Fraker Jr, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., January 1, 2003; 41(1): 159 - 168. [Full Text] [PDF]

				M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]

				M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert 35 years of experimental research in transmyocardial revascularization: what have we learned? Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970. [Abstract] [Full Text] [PDF]

				S. Ozaki, B. Meyns, R. Racz, E. Verbeken, V. Leunens, P. Dohmen, and W. Flameng Effect of transmyocardial laser revascularization on chronic ischemic hearts in sheep Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 404 - 410. [Abstract] [Full Text] [PDF]

				L. Y. Lee, M. F. O'Hara, E. B. Finnin, R. Hachamovitch, M. Szulc, P. D. Kligfield, P. M. Okin, O. W. Isom, and T. K. Rosengart Transmyocardial laser revascularization with excimer laser: clinical results at 1 year Ann. Thorac. Surg., August 1, 2000; 70(2): 498 - 503. [Abstract] [Full Text] [PDF]

				L. Aaberge, K. Nordstrand, M. Dragsund, K. Saatvedt, K. Endresen, S. Golf, O. Geiran, M. Abdelnoor, and K. Forfang Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: Clinical results from The Norwegian Randomized Trial J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1170 - 1177. [Abstract] [Full Text] [PDF]

				K. B. Allen, R. D. Dowling, A. J. DelRossi, F. Realyvasques, E. A. Lefrak, T. A. Pfeffer, T. L. Fudge, M. Mostovych, D. Schuch, S. Szentpetery, et al. TRANSMYOCARDIAL LASER REVASCULARIZATION COMBINED WITH CORONARY ARTERY BYPASS GRAFTING: A MULTICENTER, BLINDED, PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 540 - 549. [Abstract] [Full Text] [PDF]

				C. R. Bridges Myocardial laser revascularization: the controversy and the data Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662. [Abstract] [Full Text] [PDF]

				O.H. Frazier, R. J. March, K. A. Horvath, and The Transmyocardial Carbon Dioxide Laser Revascula Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery Disease N. Engl. J. Med., September 30, 1999; 341(14): 1021 - 1028. [Abstract] [Full Text] [PDF]

				O. Reuthebuch, T. Podzuweit, S. Thomas, K. Binz, M. Roth, W.-P. Klovekorn, and E. P. Bauer Transmyocardial laser revascularisation has no beneficial effect on high energy phosphates and lactate content during acute myocardial ischaemia in pigs Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 144 - 149. [Abstract] [Full Text] [PDF]

				T. Al-Sheikh, K. B. Allen, S. P. Straka, D. A. Heimansohn, R. L. Fain, G. D. Hutchins, S. G. Sawada, D. P. Zipes, and E. D. Engelstein Cardiac Sympathetic Denervation After Transmyocardial Laser Revascularization Circulation, July 13, 1999; 100(2): 135 - 140. [Abstract] [Full Text] [PDF]

				G. Lutter, M. Yoshitake, N. Takahashi, E. Nitzsche, J. Martin, K. Sarai, C. Lutz, and Friedhelm Beyersdorf Transmyocardial laser - revascularization: experimental studies on prolonged acute regional ischemia Eur. J. Cardiothorac. Surg., June 1, 1999; 13(6): 694 - 701. [Abstract] [Full Text] [PDF]

				A. Diegeler, J. Schneider, B. Lauer, F.W. Mohr, and R. Kluge Transmyocardial laser revascularization using the Holium-YAG laser for treatment of end stage coronary artery disease Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 392 - 397. [Abstract] [Full Text] [PDF]

				S.M. Burns, L.D. Sharples, S. Tait, N. Caine, J. Wallwork, and P.M. Schofield The transmyocardial laser revascularization international registry report Eur. Heart J., January 1, 1999; 20(1): 31 - 37. [Abstract] [PDF]

				G. Lutter, J. Schwarzkopf, C. Lutz, J. Martin, and F. Beyersdorf Histologic Findings of Transmyocardial Laser Channels After Two Hours Ann. Thorac. Surg., May 1, 1998; 65(5): 1437 - 1439. [Abstract] [Full Text] [PDF]

				J. T. Beranek Why Do Channels Remain Patent After Transmyocardial Laser Revascularization? Ann. Thorac. Surg., April 1, 1998; 65(4): 1200 - 1200. [Full Text] [PDF]

				R. Schulz, C. Kappeler, H. Coenen, A. Bockisch, and G. Heusch Positron Emission Tomography Analysis of [1-11C]Acetate Kinetics in Short-term Hibernating Myocardium Circulation, March 17, 1998; 97(10): 1009 - 1016. [Abstract] [Full Text] [PDF]

				A. Milano, S. Pratali, G. Tartarini, R. Mariotti, M. De Carlo, G. Paterni, G. Boni, and U. Bortolotti Early Results of Transmyocardial Revascularization With a Holmium Laser Ann. Thorac. Surg., March 1, 1998; 65(3): 700 - 704. [Abstract] [Full Text] [PDF]

				X. M. Mueller, H. H. Tevaearai, C.-Y. Genton, D. Bettex, and L. K. von Segesser Transmyocardial laser revascularisation in acutely ischaemic myocardium Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 170 - 175. [Abstract] [Full Text] [PDF]

				P. E. Fisher, T. Khomoto, C. M. DeRosa, H. M. Spotnitz, C. R. Smith, and D. Burkhoff Histologic Analysis of Transmyocardial Channels: Comparison of CO2 and Holmium:YAG Lasers Ann. Thorac. Surg., August 1, 1997; 64(2): 466 - 472. [Abstract] [Full Text]

				B. J. deGuzman, D. B. Lautz, F. Y. Chen, R. G. Laurence, R. M. Ahmad, K. A. Horvath, and L. H. Cohn Thoracoscopic Transmyocardial Laser Revascularization Ann. Thorac. Surg., July 1, 1997; 64(1): 171 - 174. [Abstract] [Full Text]

				T. Kohmoto, P. E. Fisher, A. Gu, S.-M. Zhu, C. M. DeRosa, C. R. Smith, and D. Burkhoff Physiology, Histology, and 2-Week Morphology of Acute Transmyocardial Channels Made With a CO2 Laser Ann. Thorac. Surg., May 1, 1997; 63(5): 1275 - 1283. [Abstract] [Full Text]

				K. A. Horvath, L. H. Cohn, D. A. Cooley, J. R. Crew, O. H. Frazier, B. P. Griffith, K. Kadipasaoglu, A. Lansing, F. Mannting, R. March, et al. TRANSMYOCARDIAL LASER REVASCULARIZATION: RESULTS OF A MULTICENTER TRIAL WITH TRANSMYOCARDIAL LASER REVASCULARIZATION USED AS SOLE THERAPY FOR END-STAGE CORONARY ARTERY DISEASE J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 645 - 654. [Abstract] [Full Text]

				P. Whittaker and R. A. Kloner Transmural Channels as a Source of Blood Flow to Ischemic Myocardium?: Insights From the Reptilian Heart Circulation, March 18, 1997; 95(6): 1357 - 1359. [Full Text]

				T. Kohmoto, M. Argenziano, N. Yamamoto, K. A. Vliet, A. Gu, C. M. DeRosa, P. E. Fisher, H. M. Spotnitz, D. Burkhoff, and C. R. Smith Assessment of Transmyocardial Perfusion in Alligator Hearts Circulation, March 18, 1997; 95(6): 1585 - 1591. [Abstract] [Full Text]

				E. D. Jansen, M. Frenz, K. A. Kadipasaoglu, T. J. Pfefer, H. J. Altermatt, M. Motamedi, and A. J. Welch Laser-Tissue Interaction During Transmyocardial Laser Revascularization Ann. Thorac. Surg., March 1, 1997; 63(3): 640 - 647. [Abstract] [Full Text]

				N. Gassler, H.-O. Wintzer, H.-M. Stubbe, A. Wullbrand, and U. Helmchen Transmyocardial Laser Revascularization: Histological Features in Human Nonresponder Myocardium Circulation, January 21, 1997; 95(2): 371 - 375. [Abstract] [Full Text]

				K. J. Fleischer, P. J. Goldschmidt-Clermont, J. D. Fonger, G. M. Hutchins, R. H. Hruban, and W. A. Baumgartner One-Month Histologic Response of Transmyocardial Laser Channels With Molecular Intervention Ann. Thorac. Surg., October 1, 1996; 62(4): 1051 - 1058. [Abstract] [Full Text]

				D. Burkhoff, P. E. Fisher, M. Apfelbaum, T. Kohmoto, C. M. DeRosa, and C. R. Smith Histologic Appearance of Transmyocardial Laser Channels After 4{1/2} Weeks Ann. Thorac. Surg., May 1, 1996; 61(5): 1532 - 1534. [Abstract] [Full Text]

				T. Kohmoto, P. E. Fisher, A. Gu, S.-M. Zhu, O. J. Yano, H. M. Spotnitz, C. R. Smith, and D. Burkhoff Does Blood Flow Through Holmium:YAG Transmyocardial Laser Channels? Ann. Thorac. Surg., March 1, 1996; 61(3): 861 - 868. [Abstract] [Full Text]